Development and validation of a high-performance liquid chromatography with tandem mass spectrometry method for quantification of tofacitinib in human plasma
Introduction. The use of tofacitinib as a pharmacological treatment for rheumatoid arthritis remains relevant in the light of the predicted increase in prevalence of the disease. At the same time, due to the withdrawal of several foreign pharmaceutical companies from the Russian pharmaceutical marke...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2024-06-01
|
| Col·lecció: | Разработка и регистрация лекарственных средств |
| Matèries: | |
| Accés en línia: | https://www.pharmjournal.ru/jour/article/view/1838 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|